Estonian cell therapy CDMO providing EU-GMP-compliant development, manufacturing, and customization of cell-based products for clinical and experimental use
Estonian cell therapy CDMO providing EU-GMP-compliant development, manufacturing, and customization of cell-based products for clinical and experimental use. Its capabilities include cell isolation, culture and expansion, analytical and quality services, and clinical manufacturing. The company also develops regenerative cell therapy approaches, including work in vascular disease.